Literature DB >> 1951563

Incidence and prevalence of human immunodeficiency virus infection in a prenatal population undergoing routine voluntary human immunodeficiency virus screening, July 1987 to June 1990.

M K Lindsay1, H B Peterson, S Willis, B A Slade, J Gramling, H Williams, L Klein.   

Abstract

To characterize the epidemiologic characteristics of human immunodeficiency virus type 1 infection in an urban prenatal population in the southeastern United States, we conducted serial routine voluntary antenatal human immunodeficiency virus antibody testing and obtained self-reported human immunodeficiency virus risk behavior profiles on women registering for prenatal care. From July 1987 to June 1990, 23,432 women registered for prenatal care. The majority of women (95%) consented to human immunodeficiency virus antibody testing and completed risk behavior profiles. The cumulative incidence of human immunodeficiency virus infection increased from 3.5 per 1000 in 1987 and 1988 to 5.3 per 1000 in 1989 and 1990. A history of "crack" cocaine use emerged as a significant risk factor for infection (p less than 0.01). The majority (70%) of human immunodeficiency virus-infected women did not self-acknowledge risk factors for infection and would not have been identified if screening had been targeted. The increasing incidence of human immunodeficiency virus type 1 infection in our prenatal population reinforces the need for our continued routine voluntary antenatal human immunodeficiency virus screening and risk behavior assessment.

Entities:  

Mesh:

Year:  1991        PMID: 1951563     DOI: 10.1016/0002-9378(91)90448-z

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Determinants of antepartum human immunodeficiency virus testing in a non-Medicaid obstetric population.

Authors:  E Cardonick; S Daly; M Dooley; K Elles; N S Silverman
Journal:  Infect Dis Obstet Gynecol       Date:  1998

2.  Risk factors for HIV infection overlooked in routine antenatal care.

Authors:  J Hawken; T Chard; K Costeloe; D J Jeffries; C N Hudson
Journal:  J R Soc Med       Date:  1995-11       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.